You need to login...
If you are not registered...
| Subscribe to Krixos Health: | |
|
or call us on: +43 (0)1 27 63 015 or email: subscribe@krixos.com |
|
Most viewed
- 1. Prostate cancer discovery opens door to more tailored treatments
- 2. Prostate cancer, race and the need for tests | Letters
- 3. Human medicines European public assessment report (EPAR): Zadenvi, denosumab, Status: Opinion
- 4. Medtronic Expand URO U.S. clinical trial meets safety and effectiveness primary endpoints for Hugo™ robotic-assisted surgery system
- 5. Revealing propionate metabolism-related genes in glioblastoma and investigating their underlying mechanisms
- 6. Discovery of FOXR2 activation in various brain tumours refines diagnosis to improve care
- 7. IV medication could be taken orally for range of cancer, Alzheimer's treatments
- 8. Solid subtype of adenoid cystic carcinoma of the breast with multiple distant metastases: a case report and literature review
- 9. Development and validation of a preoperative magnetic resonance imaging-based and machine learning model for the noninvasive differentiation of intracranial glioblastoma, primary central nervous system lymphoma and brain metastases: a retrospective analysis
- 10. Three-dimensional gene hubs may promote brain cancer
Last updated at 11:19 GMT
Hot News Makers
Health/Pharma Companies
-
145717.67
-
59368.54
-
55633.56
-
36603.21
-
32588.62
-
26929.11
-
13756.55
-
10087.77
-
5526.43
-
4404.53
Drugs, Treatments, Trials
-
67456.49
-
49402.69
-
17520.74
-
14745.73
-
12697.36
-
11290.18
-
8050.80
-
5384.30
-
5296.34
-
3420.13
Last updated at 11:10 GMT
